Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder

NCT00962104 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

391

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: Atomoxetine
DRUG: Placebo

Sponsor

Eli Lilly and Company